Amorepacific, a renowned South Korean health and beauty conglomerate, has reported robust results for the third quarter. The company attributes this success to the global expansion of its primary beauty brands.
For the quarter that concluded in September, the consolidated revenue witnessed a 4% increase year on year, reaching US$752 million, whereas the operating profit experienced a significant surge of 41%, amounting to $71 million.
The domestic market also performed well, presenting a 4% increase in revenue and a 24% rise in operating profit. The company credits this rise to increased sales across various channels such as online platforms, department stores, multi-brand shops, and duty-free and cross-border platforms.
Internationally, the company saw a 3% growth in revenue and an impressive 73% leap in operating profit. This growth is seen as a result of the company’s consistent expansion efforts in global markets.
In terms of individual brands, Innisfree topped with a revenue of $338.6 million. This was closely followed by Etude with a revenue of $192.4 million, Amos Professional at $138.7 million, Osulloc at $185.6 million, and Espoir at $129.2 million.
The company stated, “The robust performance of our flagship brands, coupled with continued efficiency measures, has allowed us to bolster both growth and profitability across markets.”
What is the key factor behind Amorepacific’s robust Q3 results?
The company attributes its solid Q3 performance to the global expansion of its main beauty brands.
Which brand performed the best in terms of revenue?
Innisfree topped the chart with a revenue of $338.6 million.
How did the company perform in the domestic and international markets?
Amorepacific saw a 4% increase in domestic revenue and a 3% growth in international revenue. The operating profit rose 24% domestically and jumped 73% internationally.
